1. Friedman DS, O'Colmain BJ, Muñoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004; 122:564–572.
Article
2. Park SJ, Kwon KE, Choi NK, et al. Prevalence and incidence of exudative age-related macular degeneration in South Korea: a nationwide population-based study. Ophthalmology. 2015; 122:2063–2070.e1.
3. Bressler SB, Bressler NM, Fine SL, et al. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol. 1982; 93:157–163.
Article
4. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006; 355:1432–1444.
Article
5. Heier JS, Brown DM, Chong V, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012; 119:2537–2548.
Article
6. La TY, Cho E, Kim EC, et al. Prevalence and risk factors for age-related macular degeneration: Korean National Health and Nutrition Examination Survey 2008–2011. Curr Eye Res. 2014; 39:1232–1239.
Article
7. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355:1419–1431.
Article
8. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2:e106–e116.
Article
9. Yoon KC, Mun GH, Kim SD, et al. Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008–2009. Korean J Ophthalmol. 2011; 25:421–433.
Article
10. Cho BJ, Heo JW, Kim TW, et al. Prevalence and risk factors of age-related macular degeneration in Korea: the Korea National Health and Nutrition Examination Survey 2010–2011. Invest Ophthalmol Vis Sci. 2014; 55:1101–1108.
Article
11. Obata R, Yanagi Y, Inoue T, et al. Prevalence and factors associated with age-related macular degeneration in a southwestern island population of Japan: the Kumejima Study. Br J Ophthalmol. 2018; 102:1047–1053.
Article
12. Jin G, Ding X, Xiao W, et al. Prevalence of age-related macular degeneration in rural southern China: the Yangxi Eye Study. Br J Ophthalmol. 2018; 102:625–630.
Article
13. Song P, Du Y, Chan KY, et al. The national and subnational prevalence and burden of age-related macular degeneration in China. J Glob Health. 2017; 7:020703.
Article
14. Keel S, Xie J, Foreman J, et al. Prevalence of age-related macular degeneration in Australia: The Australian National Eye Health Survey. JAMA Ophthalmol. 2017; 135:1242–1249.
15. Colijn JM, Buitendijk GHS, Prokofyeva E, et al. Prevalence of age-related macular degeneration in Europe: the past and the future. Ophthalmology. 2017; 124:1753–1763.
16. Sedeh FB, Scott DAR, Subhi Y, Sørensen TL. Prevalence of neovascular age-related macular degeneration and geographic atrophy in Denmark. Dan Med J. 2017; 64:A5422.
17. Hwang HS, Lee SB, Jee D. Association between blood lead levels and age-related macular degeneration. PLoS One. 2015; 10:e0134338.
Article
18. Kim EC, Cho E, Jee D. Association between blood cadmium level and age-related macular degeneration in a representative Korean population. Invest Ophthalmol Vis Sci. 2014; 55:5702–5710.
Article
19. Kim EC, Han K, Jee D. Inverse relationship between high blood 25-hydroxyvitamin D and late stage of age-related macular degeneration in a representative Korean population. Invest Ophthalmol Vis Sci. 2014; 55:4823–4831.
Article
20. Fujiwara S, Zhao X, Teoh C, et al. Disease burden of fractures among patients with osteoporosis in Japan: health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs. J Bone Miner Metab. 2019; 37:307–318.
Article
21. Shin WG, Kim HU, Kim SG, et al. Work productivity and activity impairment in gastroesophageal reflux disease in Korean full-time employees: a multicentre study. Dig Liver Dis. 2012; 44:286–291.
Article
22. Patel VD, Watanabe JH, Strauss JA, Dubey AT. Work productivity loss in patients with dry eye disease: an online survey. Curr Med Res Opin. 2011; 27:1041–1048.
Article
23. Lim SJ, Kim HJ, Nam CM, et al. Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database. J Prev Med Public Health. 2009; 42:251–260.
Article
24. Chang HS, Kim HJ, Nam CM, et al. The socioeconomic burden of coronary heart disease in Korea. J Prev Med Public Health. 2012; 45:291–300.
Article